Get startedLog in
    Picture of Bavarian Nordic A/S logo

    BAVA — Bavarian Nordic A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Brief: Bavarian Nordic Starts Phase 3 Study Of Chikungunya Vaccine In Children

    Picture of Bavarian Nordic A/S logoBavarian Nordic A/S
    12/06/2025 07:10
    June 12 (Reuters) - Bavarian Nordic A/S BAVA.CO:

INITIATES PHASE 3 STUDY OF CHIKUNGUNYA VACCINE IN CHILDREN

PRIMARY RESULTS FROM STUDY ARE ANTICIPATED IN FIRST HALF OF 2028

Source text: ID:nGNE44gmPp

Further company coverage: BAVA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Bavarian Nordic A/S

    See all news